{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:05:13Z","timestamp":1792692313445,"version":"4.5.0"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2014,6,9]],"date-time":"2014-06-09T00:00:00Z","timestamp":1402272000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0099071","type":"journal-article","created":{"date-parts":[[2014,6,9]],"date-time":"2014-06-09T20:38:57Z","timestamp":1402346337000},"page":"e99071","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":47,"title":["Topical Rapamycin as a Treatment for Fibrofolliculomas in Birt-Hogg-Dub\u00e9 Syndrome: A Double-Blind Placebo-Controlled Randomized Split-Face Trial"],"prefix":"10.1371","volume":"9","clinical-trial-number":[{"clinical-trial-number":"nct00928798","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Lieke M. C.","family":"Gijezen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marigje","family":"Vernooij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herm","family":"Martens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlene E. U.","family":"Oduber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles J. M.","family":"Henquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo M.","family":"Starink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin H.","family":"Prins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred H.","family":"Menko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patty J.","family":"Nelemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice A. M.","family":"van Steensel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,6,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF00582068","article-title":"Perifollicular fibromatosis cutis with polyps of the colon\u2014a cutaneo-intestinal syndrome sui generis","volume":"253","author":"OP Hornstein","year":"1975","journal-title":"Arch Dermatol Res"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1001\/archderm.1977.01640120042005","article-title":"Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons","volume":"113","author":"AR Birt","year":"1977","journal-title":"Arch Dermatol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1164\/rccm.200610-1483OC","article-title":"Lung cysts, spontaneous pneumothorax, and genetic associations in 89 families with Birt-Hogg-Dub\u00e9 syndrome","volume":"175","author":"JR Toro","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0190-9622(08)82049-X","article-title":"Bilateral renal cell carcinoma in the Birt-Hogg-Dub\u00e9 syndrome","volume":"29","author":"JS Roth","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"ref5","first-page":"1195","article-title":"Birt-Hogg-Dub\u00e9 syndrome: a novel marker of kidney neoplasia","volume":"135","author":"JR Toro","year":"1999","journal-title":"Arch Dermatol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1097\/00000478-200212000-00002","article-title":"Renal tumors in the Birt-Hogg-Dub\u00e9 syndrome","volume":"26","author":"CP Pavlovich","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-2230.2005.01764.x","article-title":"Multiple hereditary facial papules","volume":"30","author":"WI Al-Daraji","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"ref8","first-page":"1287","article-title":"Letter: hyfrecation and curettage as a treatment for fibrofolliculomas in Birt-Hogg-Dub\u00e9 syndrome","volume":"33","author":"PB Farrant","year":"2007","journal-title":"Dermatol Surg"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1067\/mjd.2000.109294","article-title":"Treatment of Birt-Hogg-Dub\u00e9 syndrome with erbium:YAG laser","volume":"43","author":"T Gambichler","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"ref10","first-page":"98","article-title":"Birt-Hogg-Dub\u00e9 syndrome: treatment of cutaneous manifestations with laser skin resurfacing","volume":"137","author":"CI Jacob","year":"2001","journal-title":"Arch Dermatol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1086\/323744","article-title":"Birt-Hogg-Dub\u00e9 syndrome, a genodermatosis associated with spontaneous pneumothorax and kidney neoplasia, maps to chromosome 17p11.2","volume":"69","author":"LS Schmidt","year":"2001","journal-title":"Am J Hum Genet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1535-6108(02)00104-6","article-title":"Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dub\u00e9 syndrome","volume":"2","author":"ML Nickerson","year":"2002","journal-title":"Cancer Cell"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Tsun ZY, Bar-Peled L, Chantranupong L, Zoncu R, Wang T, <etal>et al<\/etal>.. (2013) The Folliculin Tumor Suppressor Is a GAP for the RagC\/D GTPases That Signal Amino Acid Levels to mTORC1. Mol Cell. [Online] 2013 Oct 3. Available from: doi.org\/10.1016\/j.molcel.2013.09.016. [Accessed 13th November 2013]","DOI":"10.1016\/j.molcel.2013.09.016"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"15552","DOI":"10.1073\/pnas.0603781103","article-title":"Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling","volume":"103","author":"M Baba","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/jnci\/djm288","article-title":"Kidney-targeted Birt-Hogg-Dub\u00e9 gene inactivation in a mouse model: Erk1\/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys","volume":"100","author":"M Baba","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e3581","DOI":"10.1371\/journal.pone.0003581","article-title":"Deficiency of FLCN in mouse kidney led to development of polycystic kidneys and renal neoplasia","volume":"3","author":"J Chen","year":"2008","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"18722","DOI":"10.1073\/pnas.0908853106","article-title":"Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2","volume":"106","author":"Y Hasumi","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/PAS.0b013e3182475240","article-title":"Pulmonary cysts of Birt-Hogg-Dub\u00e9 syndrome: a clinicopathologic and immunohistochemical study of 9 families","volume":"36","author":"M Furuya","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ng1494","article-title":"Dysregulation of the TSC-mTOR pathway in human disease","volume":"37","author":"K Inoki","year":"2005","journal-title":"Nat Genet"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"24583","DOI":"10.1074\/jbc.M700857200","article-title":"The Birt-Hogg-Dub\u00e9 and tuberous sclerosis complex homologs have opposing roles in amino acid homeostasis in Schizosaccharomyces pombe","volume":"282","author":"M van Slegtenhorst","year":"2007","journal-title":"J Biol Chem"},{"key":"ref21","unstructured":"Toro JR (2008) Birt-Hogg-Dub\u00e9 Syndrome. In: Pagon RA, Adam MP, Bird TD, Dolan CR, Fong CT <etal>et al<\/etal>.., editors. GeneReviews. Seattle (WA) [Online] 2008 Sept 9. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/www.ncbi.nlm.nih.gov\/books\/NBK1522\" xlink:type=\"simple\">http:\/www.ncbi.nlm.nih.gov\/books\/NBK1522<\/ext-link>. [Accessed 10th June 2013]"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1016\/j.jaad.2004.11.021","article-title":"Multiple facial angiofibromas: a cutaneous manifestation of Birt-Hogg-Dub\u00e9 syndrome","volume":"53","author":"JV Schaffer","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2133.2008.08677.x","article-title":"The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis","volume":"159","author":"GF Hofbauer","year":"2008","journal-title":"Br J Dermatol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/archdermatol.2010.125","article-title":"Topical rapamycin: a novel approach to facial angiofibromas in tuberous sclerosis","volume":"146","author":"AK Haemel","year":"2010","journal-title":"Arch Dermatol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1365-2133.2011.10471.x","article-title":"A topical combination of rapamycin and tacrolimus for the treatment of angiofibroma due to tuberous sclerosis complex (TSC): a pilot study of nine Japanese patients with TSC of different disease severity","volume":"165","author":"M Wataya-Kaneda","year":"2011","journal-title":"Br J Dermatol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/j.1365-2133.2011.10476.x","article-title":"Treatment of facial angiofibromas with topical application of oral rapamycin solution (1mgmL(-1)) in two patients with tuberous sclerosis","volume":"165","author":"MM Mutizwa","year":"2011","journal-title":"Br J Dermatol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3109\/09546634.2010.489598","article-title":"Successful treatment of angiofibromata of tuberous sclerosis complex with rapamycin","volume":"23","author":"E Kaufman McNamara","year":"2012","journal-title":"J Dermatolog Treat"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1440-0960.2011.00837.x","article-title":"Topical 0.1% rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: a pilot study of four patients","volume":"53","author":"RS Foster","year":"2012","journal-title":"Australas J Dermatol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5070\/D36TB7N61M","article-title":"Facial angiofibromas treated with topical rapamycin: an excellent choice with fast response","volume":"18","author":"T Truchuelo","year":"2012","journal-title":"Dermatol Online J"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1001\/archdermatol.2011.254","article-title":"Dramatic improvement of facial angiofibromas in tuberous sclerosis with topical rapamycin: optimizing a treatment protocol","volume":"147","author":"CM DeKlotz","year":"2011","journal-title":"Arch Dermatol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.clinthera.2005.02.009","article-title":"Topical retinoids in inflammatory acne: a retrospective, investigator-blinded, vehicle-controlled, photographic assessment","volume":"27","author":"JJ Leyden","year":"2005","journal-title":"Clin Ther"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta9010","article-title":"Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne","volume":"9","author":"M Ozolins","year":"2005","journal-title":"Health Technol Assess"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e65869","DOI":"10.1371\/journal.pone.0065869","article-title":"Genetic Characterization of the Birt-Hogg-Dub\u00e9 Syndrome Gene","volume":"8","author":"W Liu","year":"2013","journal-title":"PLoS One"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/jmg.2009.072009","article-title":"Renal tumour suppressor function of the Birt-Hogg-Dub\u00e9 syndrome gene product folliculin","volume":"47","author":"V Hudon","year":"2010","journal-title":"J Med Genet"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/onc.2009.14","article-title":"The role of the Birt-Hogg-Dub\u00e9 protein in mTOR activation and renal tumorigenesis","volume":"28","author":"TR Hartman","year":"2009","journal-title":"Oncogene"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nrurol.2010.140","article-title":"Neuroendocrine carcinoma in a patient with Birt-Hogg-Dub\u00e9 syndrome","volume":"7","author":"T Claessens","year":"2010","journal-title":"Nat Rev Urol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cell.2013.03.012","article-title":"Exit from pluripotency is gated by intracellular redistribution of the bHLH transcription factor Tfe3","volume":"153","author":"J Betschinger","year":"2013","journal-title":"Cell"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/sj.jid.5700592","article-title":"Novel mutations in the BHD gene and absence of loss of heterozygosity in fibrofolliculomas of Birt-Hogg-Dub\u00e9 patients","volume":"127","author":"MA van Steensel","year":"2007","journal-title":"J Invest Dermatol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s10689-013-9600-8","article-title":"Birt-Hogg-Dub\u00e9 syndrome and the skin","volume":"12","author":"M Vernooij","year":"2013","journal-title":"Fam Cancer"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Luijten MN, Basten SG, Claessens T, Vernooij M, Scott CL, <etal>et al<\/etal>.. (2013) Birt-Hogg-Dub\u00e9 syndrome is a novel ciliopathy. Hum Mol Genet. [Online] 2013 Juli 6. Available from doi: 10.1093\/hmg\/ddt288 [Accessed 31st July 2013]","DOI":"10.1093\/hmg\/ddt288"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1365-2133.1965.tb14578.x","article-title":"The effect of particle size and vehicle on the percutaneous absorption of fluocinolone acetonide","volume":"77","author":"CW Barrett","year":"1965","journal-title":"Br J Dermatol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/jps.2600570603","article-title":"Effect of topical vehicle composition on the in vitro release of fluocinolone acetonide and its acetate ester","volume":"57","author":"BJ Poulsen","year":"1968","journal-title":"J Pharm Sci"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0928-0987(98)00010-4","article-title":"Influence of propylene glycol and isopropyl myristate on the in vitro percutaneous penetration of diclofenac sodium from carbopol gels","volume":"7","author":"A Arellano","year":"1999","journal-title":"Eur J Pharm Sci"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jconrel.2004.12.007","article-title":"Synergistic enhancement of testosterone transdermal delivery","volume":"103","author":"JA Nicolazzo","year":"2005","journal-title":"J Control Release"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0099071","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T05:54:40Z","timestamp":1649310880000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0099071"}},"subtitle":[],"editor":[{"given":"Maria Fiammetta","family":"Romano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,6,9]]},"references-count":44,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,6,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0099071","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,9]]}}}